当前位置：
X-MOL 学术
›
Jpn. J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A systematic literature review of prognostic factors in patients with HR+/HER2− advanced breast cancer in Japan
Japanese Journal of Clinical Oncology ( IF 2.4 ) Pub Date : 2021-08-21 , DOI: 10.1093/jjco/hyab131 Masaya Hattori 1 , Diego Novick 2 , Kana Takaura 3 , Yoshinori Tanizawa 3 , Tsutomu Kawaguchi 3 , Josep Maria Haro 4 , Anna Monistrol-Mula 4 , Akira Onishi 5 , Hiroji Iwata 1
Japanese Journal of Clinical Oncology ( IF 2.4 ) Pub Date : 2021-08-21 , DOI: 10.1093/jjco/hyab131 Masaya Hattori 1 , Diego Novick 2 , Kana Takaura 3 , Yoshinori Tanizawa 3 , Tsutomu Kawaguchi 3 , Josep Maria Haro 4 , Anna Monistrol-Mula 4 , Akira Onishi 5 , Hiroji Iwata 1
Affiliation
Breast cancer is the most prevalent cancer in women in Japan and the fifth in mortality. This systematic review summarized the evidence for prognostic factors for patients with HR+/HER2− advanced and metastatic breast cancer in Japan.
中文翻译：
日本 HR+/HER2− 晚期乳腺癌患者预后因素的系统文献回顾
乳腺癌是日本女性中最常见的癌症，死亡率排名第五。本系统评价总结了日本 HR+/HER2- 晚期和转移性乳腺癌患者预后因素的证据。
更新日期：2021-10-07
中文翻译：
日本 HR+/HER2− 晚期乳腺癌患者预后因素的系统文献回顾
乳腺癌是日本女性中最常见的癌症，死亡率排名第五。本系统评价总结了日本 HR+/HER2- 晚期和转移性乳腺癌患者预后因素的证据。
京公网安备 11010802027423号